OrbiMed Royalty & Credit Opportunities IV, LP — Form D/A
OrbiMed Royalty & Credit Opportunities IV, LP of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-12-16. The offering totals $1.8B, of which $1.2B was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-12-16
- Form: D/A
- Accession: 0001920649-22-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Total offering: $1.8B
- Amount sold: $1.2B
- Remaining: $596.9M
- Investors: 113
- Date of first sale: 2022-04-29
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-443752
Issuer
- Name: OrbiMed Royalty & Credit Opportunities IV, LP
- CIK: 0001920649
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 601 LEXINGTON AVENUE, NEW YORK, NY, 10022
- Phone: 212-739-6400
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| David P Bonita | Executive Officer | New York, NY |
| Sven H Borho | Executive Officer | New York, NY |
| Carl L Gordon | Executive Officer | Stamford, CT |
| Geoffrey C Hsu | Executive Officer | New York, NY |
| W. Carter Neild | Executive Officer | NEW YORK, NY |
| N/A OrbiMed Advisors LLC | Executive Officer | New York, NY |
| N/A OrbiMed ROF IV LLC | Executive Officer | New York, NY |
| Matthew S Rizzo | Executive Officer | New York, NY |
| C. Scotland Stevens | Executive Officer | New York, NY |
| Peter A Thompson | Executive Officer | New York, NY |
Other filings by this issuer (1)
More